New Tau PET Tracer Offers Early Alzheimer’s Detection with Precision
A new tau PET radiotracer, 18F-SNFT-1, has been found to be more effective than existing tau PET radiotracers in identifying Alzheimer’s disease in its earliest stages.
A new tau PET radiotracer, 18F-SNFT-1, has been found to be more effective than existing tau PET radiotracers in identifying Alzheimer’s disease in its earliest stages.
New research highlights that PSMA PET/CT imaging can potentially diagnose advanced prostate cancer and guide treatment decisions without the need for biopsies in elderly patients, offering accurate staging data and potentially reducing complications associated with biopsies.
By monitoring early-response biomarkers in men undergoing 177Lu-PSMA prostate cancer treatment, physicians can personalize dosing intervals, significantly improving patient outcomes.
Physicians and scientists from University of California, Los Angeles will discuss research and clinical trial results on combination therapies for breast cancer, a new treatment for recurrent glioma, and advances in PSMA PET guided radiotherapy for prostate cancer at the American Society of Clinical Oncology’s annual meeting.
Read MoreMITA, CORAR, and SNMMI are commending Senators Blackburn and Baldwin for introducing the FIND Act (SB 1544), which aims to address reimbursement methodology and expand patient access to innovative diagnostic radiopharmaceutical drugs in nuclear medicine procedures.
Read MoreA newly published meta-analysis indicates that amino acid PET can accurately differentiate recurrent or progressive brain metastases from treatment-related changes.
Read MoreNew research finds that the brains of otherwise healthy military personnel who are exposed to explosions show an abnormal brain accumulation of amyloid-beta protein—a protein that plays a role in the development of Alzheimer’s disease.
Read MoreA new deep-learning-based fractional flow reserve (FFR)-CT algorithm has been developed that shows excellent diagnostic performance for hemodynamically significant stenosis and provides a rapid and accurate onsite approach to address the challenges encountered in the clinical adoption of prior FFR-CT implementations.
Read More